Omtriptolide is primarily investigated for its potential therapeutic applications, particularly in the field of cancer treatment. It has shown promise as an anti-cancer agent due to its ability to inhibit the growth of tumor cells. Studies suggest that it may induce apoptosis, or programmed cell death, in cancer cells, making it a candidate for further research in oncology. Additionally, its anti-inflammatory properties are being explored, which could lead to applications in treating inflammatory diseases or conditions. Researchers are also examining its potential role in autoimmune disorders, as it may modulate immune responses. However, more preclinical and clinical studies are needed to fully understand its efficacy and safety for human use.